Renaissance Technologies’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
|
|||||
|
2025
Q1 | $3.04M | Buy |
|
|||||
|
2024
Q4 | $2.1M | Buy |
|
|||||
|
2024
Q3 | $975K | Buy |
|
|||||
|
2024
Q2 | $941K | Sell |
|
|||||
|
2024
Q1 | $1.04M | Buy |
|
|||||
|
2023
Q4 | $1.19M | Buy |
|
|||||
|
2023
Q3 | $1.03M | Sell |
|
|||||
|
2023
Q2 | $1.32M | Sell |
|
|||||
|
2023
Q1 | $2.54M | Buy |
|
|||||
|
2022
Q4 | $308K | Buy |
|
|||||
|
2022
Q3 | $122K | Buy |
|
|||||
|
2022
Q2 | $125K | Buy |
|
|||||
|
2022
Q1 | $13K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $57K | Sell |
|
|||||
|
2021
Q1 | $2.26M | Buy |
|
|||||
|
2020
Q4 | $1.77M | Sell |
|
|||||
|
2020
Q3 | $1.9M | Sell |
|
|||||
|
2020
Q2 | $2.01M | Buy |
|
|||||
|
2020
Q1 | $1.12M | Buy |
|
|||||
|
2019
Q4 | $1.51M | Buy |
|
|||||
|
2019
Q3 | $913K | Buy |
|
|||||
|
2019
Q2 | $2.03M | Buy |
|
|||||
|
2019
Q1 | $1.77M | Buy |
|
|||||
|
2018
Q4 | $1.15M | Buy |
|
|||||
|
2018
Q3 | $2.37M | Buy |
|
|||||
|
2018
Q2 | $1.12M | Buy |
|
|||||
|
2018
Q1 | $1.25M | Buy |
|
|||||
|
2017
Q4 | $1.32M | Sell |
|
|||||
|
2017
Q3 | $1.22M | Sell |
|
|||||
|
2017
Q2 | $1.93M | Buy |
|
|||||
|
2017
Q1 | $2.62M | Buy |
|
|||||
|
2016
Q4 | $213K | Buy |
|
|||||
|
2016
Q3 | $103K | Buy |
|
|||||
|
2016
Q2 | $66K | Buy |
|
|||||
|
2016
Q1 | $46K | Buy |
|
|||||
|
2015
Q4 | $21K | Buy |
|